This is the login panel
Doctor Klein is a Diplomate of the Board of Internal Medicine and is also Board certified in Rheumatology. His undergraduate training was at the University of California (Berkeley) where he graduatated phi beta kappa in 1965. He received his MD degree from Stanford University in 1969 and spent a year at the University of Colorado for medical internship before joining the US Public Health service for 2 years of duty on an indian reservation at Pine Ridge, South Dakota.
He then continued his training at the Mayo Clinic in Rochester, Minnesota from 1972-1976 where he was awarded the Outstanding Achievement Award in Internal Medicine and the Hench award for excellence in Rheumatology. While at the Mayo Clinic he became interested in clinical research and was involved in several studies dealing with inflammation of the arteries (temporal arteritis).
He began practicing traditional internal medicine and rheumatology at
the Sansum Medical Clinic in Santa Barbara in 1976, and he continued
his practice at Sansum for 17 years. During his tenure at Sansum he
heard about prolotherapy for the first time in 1984 and attended the
inaugural meeting of the AAOM in Phoenix that year. Dr. Klein was
initially skeptical that prolotherapy was truly effective, but after
seeing the results first hand he became convinced that this was a
valuable form of treatment that deserved the attention and respect of
the medical community. After studying and mentoring with Milne Ongley
and Bjorn Eek, Dr. Klein organized the first double blind trial of
prolotherapy that was published in the Lancet. 1987 Jul
18;2(8551):143-6. An additional double blind study was published in the
Journal of Spinal Disorders 1993 Feb;6(1):23-33.
Biochemical injection treatment for discogenic low back pain: a pilot study.
The AAOM has been instrumental in fostering research and in helping to promote the use of prolotherapy and other innovative treatments that are not traditionally taught in medical schools. Dr Klein has been proud to be an AAOM member since the inaugural meeting in 1984 and has contributed to the scientific body of knowledge that supports prolotherapy as a useful treatment approach.
J Spinal Disord. 1993 Feb;6(1):23-33